CME Outfitters

12/04/2025

Newly approved therapies for cervical cancer are reshaping clinical practice. But with so many options, how do you determine the best treatment plan for your patients?

📢 Join Drs. Richard Penson & Bradley Monk as they break down the latest research, including efficacy & safety data for recently approved treatments.

🎧 Tune in now: https://cmeo.me/PD-112

Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of the latest clinical trial data and...

12/04/2025

⚙️ From pancreas to kidneys, brain to heart—GLP-1 RAs are changing the game.

Learn how they work and how to use them smarter in your practice.
🎓 Just 30 minutes → https://cmeo.me/SN-269

GLP-1 receptor agonists (GLP-1 RAs) have become a cornerstone of type 2 diabetes (T2D) treatment, with strong endorsements from the American Diabetes Association and the American Association of Clinical Endocrinology. Despite these clear guidelines, GLP-1 RAs...

12/03/2025

Effective care requires more than guidelines—it requires listening.

Join us on Jan 23 to explore how aligning patient + provider goals using shared decision-making (SDM) improves adherence and outcomes.

💬 You + Patients + Experts = Better Care
🔗 https://cmeo.me/MMS-162

Despite major advances in inflammatory bowel disease (IBD) management, real-world data show that many patients continue to experience suboptimal outcomes due to misaligned treatment goals, therapeutic inertia, and limited integration of novel therapies, particularly IL-23 inhibitors—into...

12/03/2025

Prescribing for cUTI?

This webcast breaks down how new and emerging antibiotics fit into updated IDSA/EAU guidelines.
Don't miss out on this timely session.
👉 https://cmeo.me/WC-125

Complicated urinary tract infections (cUTIs) represent an important and growing challenge in clinical practice, affecting individual patients’ health and quality of life while exerting a substantial burden on the healthcare system. Despite being common, these infections...

12/03/2025

Download the resources and collect credit - cmeo.me/SN-287-encore

12/03/2025

💉 Enhancing Pediatric Vaccination Through Science and Trust

Vaccine hesitancy continues to challenge public health, but health care professionals remain the most trusted voices for parents and caregivers.

In this free CME infographic activity, Dr. Rupali Limaye provides science-based strategies and empathetic communication tools to:
✔ Address vaccine concerns
✔ Build trust with families
✔ Promote informed, confident vaccination decisions

📌 View now: https://cmeo.me/IN-012

Vaccination has long been recognized as one of the most effective public health interventions, preventing millions of deaths and significantly reducing the incidence of infectious diseases worldwide. Despite its success, vaccine hesitancy—a reluctance or delay in...

12/03/2025

💡 AEs don’t have to derail GLP-1 RA therapy. Improve your patient counseling and support persistence in T2D treatment.
Watch the latest CME Snack:
🔗 https://cmeo.me/SN-273

GLP-1 receptor agonists (GLP-1 RAs) are powerful tools for managing type 2 diabetes (T2D) but concerns about adverse events (AEs) frequently stop patients before they start, and  patients who are not prepared to manage common side...

12/02/2025

The landscape of MASH therapy is evolving fast, from lifestyle interventions to new pharmacologic options.

Join Dr. Sonal Kumar and Dr. Zobair Younossi for an in-depth look at how clinicians can optimize patient outcomes by:
✅ Integrating emerging MASH-specific therapies
✅ Applying the ADA 2025 MASLD Guideline
✅ Strengthening interprofessional collaboration in care

🎓 Earn 0.75 CME/CE credits
👉 https://cmeo.me/SN-285

In this CME Outfitters Snack on metabolic dysfunction-associated steatotic liver disease (MASLD) / metabolic-associated steatohepatitis (MASH), expert faculty turn attention to treatment planning for Mr. B, who has been diagnosed with MASH. Discussion centers on evidence-based...

12/01/2025

New CME Snack alert! 🍽️

“Spotting the Red Flags: Screening and Risk Strat Like a Pro” helps HCPs tackle the rising challenge of MASH. Learn to identify patients at risk, apply FIB-4 calculations, and implement non-invasive assessments.

Credit available: 0.5 CME/CE → https://cmeo.me/SN-283

Metabolic dysfunction-associated steatohepatitis (MASH) is a growing clinical challenge due to its increasing prevalence, complex pathophysiology, and strong association with comorbid conditions such as cardiovascular disease and obesity. Evolving diagnostic criteria, risk stratification tools, and....

11/29/2025

Primary immunodeficiency (PI) doesn’t always present as frequent infections.

Learn how to spot atypical presentations, personalize immunoglobulin therapy, and address disparities in PI care.

🎥 Watch the CME Outfitters activity:
🔗 https://cmeo.me/SN-287

Patients living with primary immunodeficiency (PI) disorders face prolonged or severe infections that pose significant challenges to daily life. While infectious PI phenotypes have garnered the most visibility, this focus has left noninfectious variants underrecognized and...

11/29/2025

Clinical trial access should be equitable, transparent, and inclusive.

Revisit Open Enrollment: Rewriting the Rules of Access in Clinical Trials—now available on demand!

Learn actionable ways to:
✔️ Standardize your trial invitation and consent process
✔️ Address common patient barriers (transport, time, childcare, language)
✔️ Improve documentation and follow-up workflows
✔️ Advance enrollment equity across diverse patient populations

Watch now or share with your team:
🔗 https://cmeo.me/WCV-108

Individuals from underserved communities often face roadblocks to clinical trial participation, including geographic limitations, socioeconomic barriers, restrictive eligibility criteria, and systemic inequities. These challenges are compounded by unconscious bias among health care professionals (HC...

11/29/2025

Safe opioid prescribing starts with informed, compassionate care.

Revisit The Opioid REMS Advantage: Supporting Providers, Protecting Patients—now available on demand!

Learn actionable ways to:
✔️ Use validated pain assessment tools to guide individualized care
✔️ Counsel patients on multimodal pain strategies and safe disposal
✔️ Apply 2022 CDC opioid prescribing recommendations in practice
✔️ Screen for misuse risk and engage in proactive patient education

Watch now or share with your team:
🔗 https://cmeo.me/WCV-117

Chronic, subacute, and acute pain remain among the most common and complex challenges encountered in clinical practice. Inadequate pain management contributes to diminished quality of life, impaired function, and increased healthcare utilization. At the same time,...